Healthcare Innovation Hub to focus on transformative startups, advancing innovative technologies and supporting pioneering research and development that will benefit humanity

医疗创新中心专注于变革性初创企业，推进创新技术，支持有益于人类的开创性研究和开发

JERUSALEM and NEW YORK, Dec. 19, 2023 /PRNewswire/ -- Shaare Zedek Medical Center (SZMC), Jerusalem's largest multi-disciplinary medical center, and Arieli Capital, LLC (Arieli), a global multifaceted investment firm, today announced the creation of the Shaare Zedek Arieli Innovation Hub, SHAAR. This landmark center is set to become a cornerstone hub for healthcare innovation..

耶路撒冷和纽约，2023年12月19日/PRNewswire/--耶路撒冷最大的多学科医疗中心Shaare Zedek Medical Center（SZMC）和全球多方面投资公司Arieli Capital，LLC（Arieli）今天宣布成立SHAAR Shaare Zedek Arieli创新中心。这个地标性的中心将成为医疗创新的基石枢纽。。

Shaare Zedek Scientific (SZS), the research and innovation arm of SZMC, and Arieli are leading the new SHAAR Hub, which was launched with support from the Jerusalem Development Authority (JDA). SHAAR, located within the Shaare Zedek Medical Center, combines SZMC's medical expertise and world-class facilities with Arieli's investment experience and track record of fostering innovation and growth platforms..

Shaare Zedek Scientific（SZS），SZMC的研究和创新部门，以及Arieli正在领导新的SHAAR Hub，该中心是在耶路撒冷发展局（JDA）的支持下启动的。SHAAR位于Shaare Zedek医疗中心内，将深交所的医疗专业知识和世界一流的设施与Arieli的投资经验以及培育创新和增长平台的记录相结合。。

SHAAR's mission is to build a gateway between innovation and capital, creating an environment where cutting-edge medical research, pioneering projects, and forward-thinking startups can thrive through strategic financial and professional support, leading co-working space and a collaborative community.

沙尔的使命是建立创新与资本之间的门户，创造一个环境，通过战略性的财务和专业支持、领先的合作空间和合作社区，前沿医学研究、开创性项目和前瞻性创业公司可以蓬勃发展。

The hub facilitates advanced innovation programs and access to investment and funding opportunities, providing startups and medical projects with the resources needed to turn visionary healthcare ideas into impactful solutions..

该中心促进了先进的创新计划以及获得投资和资金的机会，为初创公司和医疗项目提供了将有远见的医疗保健想法转化为有影响力的解决方案所需的资源。。

United with Ariel's strong focus on fostering innovation, business and financial growth, SHAAR is where startups, investors, medical professionals and industry leaders unite to advance and support the next generation of healthcare technologies and entrepreneurs.

结合Ariel对促进创新、商业和金融增长的强烈关注，SHAAR是初创公司、投资者、医疗专业人员和行业领导者联合起来推动和支持下一代医疗技术和企业家的地方。

'SHAAR, Hebrew for Gateway, is a true embodiment of our mission,' Prof. Ofer Merin, CEO of SZMC, explained. 'Our goal is to equip entrepreneurs with direct access to physicians, clinical settings, data and samples. Such access is essential, serving as a springboard for the development of innovative medical solutions.

SZMC首席执行官奥费尔·梅林（Ofer Merin）教授解释说：“沙尔（SHAAR）希伯来语中的Gateway是我们使命的真实体现。”我们的目标是让企业家能够直接接触医生、临床环境、数据和样本。这种访问是必不可少的，是开发创新医疗解决方案的跳板。

I have no doubt that this significant partnership with Arieli Capital, led by Prof. Dan Turner and Dr. Renana Ofan, will greatly contribute to the success of this initiative.'.

我毫不怀疑，由丹·特纳（DanTurner）教授和雷纳·奥凡（Renana Ofan）博士领导的与阿里埃利资本（Arieli Capital）的这一重要合作关系，将极大地促进这一举措的成功。”。

'We are honored to partner with the Shaare Zedek Medical Center to bring the important mission of SHAAR to life,' said Evan Renov, Co-Founder and Chief Executive Officer of Arieli. 'We are eager to bring Arieli's global business expertise in growing healthcare startups to SHAAR. Our goal is to bridge the gap between promising entrepreneurs and the venture capital industry, ultimately impacting people's lives and healthcare on a global scale.'.

阿里埃利联合创始人兼首席执行官埃文·雷诺夫（EvanRenov）说，我们很荣幸与夏尔·泽德克医疗中心（Shaare Zedek Medical Center）合作，将夏尔的重要使命变为现实我们渴望将Arieli在不断成长的医疗保健初创公司方面的全球商业专业知识带到SHAAR。我们的目标是弥合有前途的企业家与风险投资行业之间的差距，最终在全球范围内影响人们的生活和医疗保健。”。

SHAAR plans to launch an open call for companies by year's end, targeting worldwide market-ready healthcare startups, to participate in the first SHAAR Scale-up cohort.

SHAAR计划在年底前针对全球市场就绪的医疗保健初创公司发起一项公开呼吁，以参与SHAAR的第一个规模扩大队列。

About SHAAR:Founded by Shaare Zedek Medical Center and Arieli Capital, SHAAR's mission is to build a gateway between innovation and capital, creating an environment where cutting-edge medical research, pioneering projects, and forward-thinking startups can thrive through strategic financial and professional support.

关于SHAAR：由Shaare Zedek医疗中心和Arieli Capital成立，SHAAR的使命是建立创新与资本之间的门户，创造一个环境，通过战略性财务和专业支持，前沿医学研究、开创性项目和前瞻性创业公司可以蓬勃发展。

The hub facilitates advanced innovation programs and access to investment and funding opportunities, providing startups and medical projects with the resources needed to turn visionary healthcare ideas into impactful solutions. SHAAR, located within the Shaare Zedek Medical Center, combines SZMC's medical expertise and world-class facilities with Arieli's investment experience and track record of fostering innovation and growth platforms.

该中心促进先进的创新计划，并获得投资和融资机会，为初创公司和医疗项目提供将有远见的医疗保健想法转化为有影响力的解决方案所需的资源。SHAAR位于Shaare Zedek医疗中心内，将SZMC的医疗专业知识和世界一流的设施与Arieli的投资经验以及培育创新和增长平台的记录相结合。

For more information, please visit www.shaarhealth.com..

有关更多信息，请访问www.shaarhealth.com。。

About Shaare Zedek Medical Center: Shaare Zedek Medical Center (SZMC) is the largest multi-disciplinary medical center in Jerusalem, treating nearly 1,000,000 patients annually in 30 inpatient departments and 70 ambulatory care units. With a constant commitment to improve and provide our patients with the best possible care, the 1000-bed facility and staff of over 4,500 people is dedicated to combining compassionate medical care with a constant attention to groundbreaking scientific research and technological development to benefit the advancement of medicine in Israel and around the world.

关于Shaare Zedek医疗中心：Shaare Zedek医疗中心（SZMC）是耶路撒冷最大的多学科医疗中心，每年在30个住院部门和70个门诊护理单位治疗近1000000名患者。该医院拥有1000张床位，员工超过4500人，致力于改善和为患者提供尽可能最好的护理，致力于将富有同情心的医疗保健与不断关注开创性的科学研究和技术发展相结合，以促进以色列和世界各地的医学进步。

For more information, please visit www.szmc.org.il/en..

有关更多信息，请访问www.szmc.org.il/en。。

About Shaare Zedek Scientific: Shaare Zedek Scientific Ltd. (SZS) is the research and innovation arm of Shaare Zedek Medical Center, Jerusalem's fastest-growing major medical center. Our goal is to act as an innovation bridge between leading companies in the fields of medical research and our hospital.

关于Shaare Zedek Scientific：Shaare Zedek Scientific Ltd.（SZS）是Shaare Zedek Medical Center的研究和创新部门，Shaare Zedek Medical Center是耶路撒冷发展最快的主要医疗中心。我们的目标是充当医学研究领域领先公司与我们医院之间的创新桥梁。

Madait's strength is in converting initial research initiatives into novel medical treatments by leveraging our hospital's abilities, facilities, patients, and team expertise for the advancement of medical science. Our daily mission is to ensure that Shaare Zedek's growing successes in research and clinical care also benefits the global healthcare community.

Madait的优势在于通过利用我们医院的能力，设施，患者和团队专业知识，将最初的研究计划转化为新颖的医疗方法，以促进医学科学的进步。我们的日常任务是确保Shaare Zedek在研究和临床护理方面不断取得的成功也有益于全球医疗保健界。

For more information, please visit www.madait.co.il..

欲了解更多信息，请访问www.madait.co.il。。

About Arieli Capital: Arieli Capital (Arieli) is a multifaceted investment firm that is an active investor and partner in the next generation of technology companies. Arieli Capital continuously strives to identify and support companies creating real impact while keeping financial returns as the primary objective.

关于Arieli Capital：Arieli Capital（Arieli）是一家多方面的投资公司，是下一代科技公司的积极投资者和合作伙伴。Arieli Capital不断努力识别和支持产生实际影响的公司，同时将财务回报作为首要目标。

Arieli is a recognized global leader in innovation. Arieli creates and operates global innovation programs across governmental, academic and corporate partnerships. For more information, please visit www.arielicapital.com.   Forward-Looking Statements.

Arieli是公认的全球创新领导者。Arieli在政府、学术和企业合作伙伴关系中创建和运营全球创新计划。有关更多信息，请访问www.arielicapital.com。前瞻性声明。

This release contains forward-looking information about Arieli Capital LLC ('Arieli') which involves substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. Accordingly, any statements included in this communication are not statements of historical facts but may be deemed to be forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995.

本新闻稿包含关于Arieli Capital LLC（“Arieli”）的前瞻性信息，该信息涉及重大风险和不确定性，可能导致实际结果与此类声明中明示或暗示的结果产生重大差异。因此，本函件中的任何陈述均不属于历史事实陈述，但根据1995年《私人证券诉讼改革法》的安全港规定，可被视为前瞻性陈述。

Forward-looking statements are, in some cases, accompanied by words such as 'may,' 'should,' 'would,' 'could,' 'plan,' 'intend,' 'anticipate,' 'believe,' 'estimate,' 'predict,' 'potential,' 'seem,' 'seek,' 'continue,' 'future,' 'will,' 'expect,' 'outlook' or other similar words, phrases or expressions and the negatives of such words, phrases or expressions.

在某些情况下，前瞻性陈述伴随着诸如“可能”、“应该”、“将会”、“可能”、“计划”、“打算”、“预期”、“相信”、“估计”、“预测”、“潜力”、“看起来”、“寻求”、“继续”、“未来”、“将会”、“期望”、“展望”或其他类似的单词、短语或表达以及这些单词、短语或表达的负面影响。

These forward-looking statements include, but are not limited to, statements regarding Arieli's expectations of future events, future opportunities, global expansion and other growth initiatives, and Arieli's investments in such initiatives. These statements are based on various assumptions and known or unknown risks, uncertainties and other factors, and actual results may differ materially.

这些前瞻性声明包括但不限于关于Arieli对未来事件、未来机会、全球扩张和其他增长举措的预期以及Arieli对此类举措的投资的声明。这些陈述基于各种假设以及已知或未知的风险、不确定性和其他因素，实际结果可能存在重大差异。

Neither Arieli nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. Arieli assumes no obligation to update any forward-looking statements or information contained in this communication except to the extent required by law..

Arieli或任何其他人均不对前瞻性陈述的准确性和完整性承担责任。Arieli不承担更新本通信中包含的任何前瞻性声明或信息的义务，除非法律要求。。

Contact:

联系人：

Arieli Capital, LLC Nataf Dgani, Head of Marketing +972-54-757-3384; [email protected]

Arieli Capital，LLC营销总监Nataf Dgani+972-54-757-3384；[受电子邮件保护]

Nurit Kantarovich, VP Strategic Partnerships+972-544416834; [email protected]

Nurit Kantarovich，战略伙伴关系副总裁+972-544416834；[受电子邮件保护]

Maya Karvat, Public Relations+972-50-575-7817; [email protected]

Maya Karvat，公共关系+972-50-575-7817；[受电子邮件保护]

Shaare Zedek Medical Cener

Shaare Zedek医疗中心

Yossi Gottesman, Spokesperson+972-50-312-1842; [email protected]

约西·戈特斯曼，发言人+972-50-312-1842；[受电子邮件保护]

Renana Ofan, CEO, Shaare Zedek Scientific +972 54-652-1911; [email protected]

Shaare Zedek Scientific首席执行官Renana Ofan+972 54-652-1911；[受电子邮件保护]

SOURCE Arieli Capital; Shaare Zedek Medical Center

来源Arieli Capital；Shaare Zedek医疗中心